JP Morgan Maintains Overweight on CG Oncology, Raises Price Target to $96
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Brian Cheng maintains CG Oncology (NASDAQ:CGON) with a Overweight and raises the price target from $91 to $96.
JP Morgan analyst Brian Cheng maintains CG Oncology (NASDAQ:CGON) with a Overweight and raises the price target from $91 to $96.